HEALTH● LOW1h ago · Oct 30, 2026, 6:00 AM
Stoke outlines Q3 2027 EMPEROR readout and plans NDA submission in second half 2027
Seeking Alpha Tech · global
Stoke Therapeutics has announced its plans for the Q3 2027 EMPEROR readout and an NDA submission in the second half of 2027. This outlines key milestones in the company's drug development pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoCAR tightens border checks tightened as DR Congo's Ebola cases riseAfricanews [en]HEALTH2h agoLiving Through the Heat: Lifestyle changes you must makeVanguard NigeriaHEALTH2h agoMore greens, higher testosterone? What a Finnish study foundEuroNews [en]HEALTH2h agoNutritional deficiencies, alcohol intake linked to venous stroke in Karnataka: NIMHANS studyThe Hindu